Nammude Arogyam October 2017 | Page 93

tcmK-e-£-W-§Ä
50% t]cn bmsXmcp e£-W-hp-an-Ãm-bn-cn-¡pw. Nne-cn BÀ¯-h-
k-a-b¯v AanX cà-{km-hw, ITn-\-amb thZ-\, cà-{kmhw BÀ¯-
hm-\-´-chpw \oïv \n¡p-I, hb-dn\pw \Sp-hn\pw thZ-\, aq{X-X-S-Êw,
ae-_-Ôw, hÔyX Chbv¡v Imc-W-am-Ip-¶p. KÀ`m-i-b-¯n\v DÅn-te¡v
XÅn-\n¡p¶ apg-I-fmWv hÔy-X-bv¡pw, KÀ`-On-{Z-¯n\pw CS-bm-Ip-
¶-Xv.
Ch t]Sn-t¡--Xp-tm?
km[m-cW KÀ`m-ib apg-IÄ
1þ2 sk.ao hÀj-¯n hf-cpw.
]t£ AXn-s\-¡mÄ thK-¯n
 hfcp¶ apg-bm-sW-¦n-tem,
ITn-\-amb cà-{km-h-hpw, thZ-
\bpw Dïm-¡p-s¶-¦n {]tXy
Iw {i²n-¡p-¶p. 1 % AÀ_p
Zamhm-\pÅ km[yX Ch-
bv¡pïv (Sarcoma). KÀ`m-i-b-
¯n\v DÅn DÅ apg-bmb
Submucus Fibroids \o¡w sN¿p-
¶-XmWv
KÀ`-h-Xn-bm-Im³
B{K-ln-¡p-¶-hÀ¡v
\Ã-Xv.
AXp-t]mse apg-bpsS hen¸w 5
sk.ao
IqSp-Xepsï-¦nepw
\o¡w sN¿p-¶Xv \Ã-Xm-Wv.
\½p-sS B-tcm-Kyw | 2017 HIvtSm_À 93